These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 36346459

  • 1. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience.
    Xu B, Lubin DJ, Dogan S, Ghossein RA, Viswanathan K.
    Virchows Arch; 2023 Mar; 482(3):479-491. PubMed ID: 36346459
    [Abstract] [Full Text] [Related]

  • 2. The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile.
    Metovic J, Vignale C, Annaratone L, Osella-Abate S, Maletta F, Rapa I, Cabutti F, Patriarca S, Gallo M, Nikiforov YE, Volante M, Papotti M.
    J Clin Endocrinol Metab; 2020 Dec 01; 105(12):. PubMed ID: 32936917
    [Abstract] [Full Text] [Related]

  • 3. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.
    Lukovic J, Petrovic I, Liu Z, Armstrong SM, Brierley JD, Tsang R, Pasternak JD, Gomez-Hernandez K, Liu A, Asa SL, Mete O.
    Front Endocrinol (Lausanne); 2021 Dec 01; 12():795184. PubMed ID: 34975765
    [Abstract] [Full Text] [Related]

  • 4. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
    Yegen G, Altay AY, Yılmaz İ, İşcan Y, Sormaz İC, Aksakal N, Önder S, Mete Ö.
    Endocr Pathol; 2023 Sep 01; 34(3):279-286. PubMed ID: 37574466
    [Abstract] [Full Text] [Related]

  • 5. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
    Bai S, Baloch ZW, Samulski TD, Montone KT, LiVolsi VA.
    Endocr Pathol; 2015 May 01; 26(2):164-9. PubMed ID: 25898815
    [Abstract] [Full Text] [Related]

  • 6. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
    Musholt PB, Musholt TJ, Morgenstern SC, Worm K, Sheu SY, Schmid KW.
    World J Surg; 2008 May 01; 32(5):722-8. PubMed ID: 18235983
    [Abstract] [Full Text] [Related]

  • 7. Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 Update.
    Bischoff LA, Ganly I, Fugazzola L, Buczek E, Faquin WC, Haugen BR, McIver B, McMullen CP, Newbold K, Rocke DJ, Russell MD, Ryder M, Sadow PM, Sherman E, Shindo M, Shonka DC, Singer MC, Stack BC, Wirth LJ, Wong RJ, Randolph GW.
    JAMA Otolaryngol Head Neck Surg; 2024 Mar 01; 150(3):265-272. PubMed ID: 38206595
    [Abstract] [Full Text] [Related]

  • 8. Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma.
    Wenter V, Albert NL, Unterrainer M, Ahmaddy F, Ilhan H, Jellinek A, Knösel T, Bartenstein P, Spitzweg C, Lehner S, Todica A.
    Eur J Nucl Med Mol Imaging; 2021 Feb 01; 48(2):449-460. PubMed ID: 32683470
    [Abstract] [Full Text] [Related]

  • 9. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D, Carlson DL, Tuttle RM, Chuai S, Ishill N, Shaha A, Shah JP, Singh B, Ghossein RA.
    Cancer; 2006 Mar 15; 106(6):1286-95. PubMed ID: 16470605
    [Abstract] [Full Text] [Related]

  • 10. Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome.
    Dettmer M, Schmitt A, Steinert H, Moch H, Komminoth P, Perren A.
    Histopathology; 2012 Jun 15; 60(7):1045-51. PubMed ID: 22348590
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathological features and outcomes after radioactive iodine treatment of oncocytic well-differentiated thyroid carcinomas.
    Amouri W, Charfeddine S, Charfi S, Jardak I, Boudawara T, Guermazi F.
    Nucl Med Commun; 2019 Sep 15; 40(9):888-893. PubMed ID: 31343615
    [Abstract] [Full Text] [Related]

  • 12. [Poorly differentiated thyroid carcinoma : An underdiagnosed entity. German version].
    Dettmer MS, Schmitt A, Komminoth P, Perren A.
    Pathologe; 2019 May 15; 40(3):227-234. PubMed ID: 31093689
    [Abstract] [Full Text] [Related]

  • 13. Poorly differentiated thyroid carcinoma : An underdiagnosed entity.
    Dettmer MS, Schmitt A, Komminoth P, Perren A.
    Pathologe; 2020 Jun 15; 41(Suppl 1):1-8. PubMed ID: 31273418
    [Abstract] [Full Text] [Related]

  • 14. Oncocytic Change in Thyroid Pathology.
    Asa SL, Mete O.
    Front Endocrinol (Lausanne); 2021 Jun 15; 12():678119. PubMed ID: 34012422
    [Abstract] [Full Text] [Related]

  • 15. High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas.
    Cracolici V, Cipriani NA.
    Endocr Pathol; 2023 Mar 15; 34(1):34-47. PubMed ID: 36692728
    [Abstract] [Full Text] [Related]

  • 16. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
    Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simões M, Tallini G, Mete O.
    Endocr Pathol; 2022 Mar 15; 33(1):27-63. PubMed ID: 35288841
    [Abstract] [Full Text] [Related]

  • 17. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
    Dettori T, Frau DV, Lai ML, Mariotti S, Uccheddu A, Daniele GM, Tallini G, Faa G, Vanni R.
    Genes Chromosomes Cancer; 2003 Sep 15; 38(1):22-31. PubMed ID: 12874783
    [Abstract] [Full Text] [Related]

  • 18. Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes.
    Matsuura D, Yuan A, Wang L, Ranganath R, Adilbay D, Harries V, Patel S, Tuttle M, Xu B, Ghossein R, Ganly I.
    Thyroid; 2022 Mar 15; 32(3):245-254. PubMed ID: 35078345
    [Abstract] [Full Text] [Related]

  • 19. Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.
    Sugitani I, Toda K, Yamamoto N, Sakamoto A, Fujimoto Y.
    World J Surg; 2010 Jun 15; 34(6):1265-73. PubMed ID: 19953247
    [Abstract] [Full Text] [Related]

  • 20. Oncocytic versus mitochondrion-rich follicular thyroid tumours: should we make a difference?
    Tsybrovskyy O, Rössmann-Tsybrovskyy M.
    Histopathology; 2009 Dec 15; 55(6):665-82. PubMed ID: 20002768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.